As the pandemic continues, the evolution of new variants of the coronavirus is on the rise. In an effort to put an end to this pandemic, several countries have been doing their best to develop/ produce the vaccines and medicines to save the world from this deadly disease.
Fortunately, different vaccines are launched in the market and are made available to the public. But how well the different vaccines are working to fight against the new variants of the virus!?
Coronavirus New Variants that are worrying the World
India's 'double mutation' coronavirus variant (latest variant)
B.1.351 also known as the South Africa coronavirus variant
B.1.1.7 also known as UK coronavirus variant
P1 also known as Brazil coronavirus variant
Are the vaccines that are available in the market are effective on all the evolving variants? Will they boost up our antibodies to fight against those variants?! If so, how many doses we need to get!? Well, it might be too early to get a perfect answer!
According to public health experts, there are four types of vaccines available in the United States; they are Pfizer, Biontech, Moderna, Johnson, and Johnson. Three of these vaccines are proved to be successfully effective in preventing the disease.
Vaccines Are Preventing Hospitalizations and Deaths
But experts say the vaccines are alike on what matters most: preventing hospitalizations and deaths. "Luckily, all these vaccines look like they're protecting us from severe disease," said Dr. Monica Gandhi of the University of California, San Francisco 
When These Vaccines Were Compared, In Connection To Which Has Higher Preventing Rate?
Pfizer and Biontech shown to have a 95% efficacy rate when compared to Moderna; It has one point higher than those two. However, these vaccines are equally preventing the symptomatic Covid across the age groups.
Clinical Trials on New Variants:
Johnson & Johnson's vaccine has shown a 72% efficacy rate for the single-dose even preventing the symptomatic Covid and most serve disease with the efficacy rate of 85% after 28days of vaccination.
As per the source, Johnson & Johnson have done different clinical trials when there is a high rate of new contagious Variants in the country!
Here is a Case Study
So, for instance, in the Pfizer COVID-19 vaccine trials, of the 43,661 people who volunteered, 170 contracted coronavirus. Of them, 162 were in the placebo group and 8 were in the vaccine group. That means the rate of illness among the vaccinated group was 95% lower than in the placebo group. Thus, the vaccine has a 95% efficacy rate .
It’s All About Immunity & Anti-Bodies
It's not about the effective vaccine, Even it's not all the failure of the clinical trials! Though a person is vaccinated or not, may get infected if the person has low levels of immune and antibodies. When the human body has a low immune system and unable to react to an antigen or antibody then there will be a higher risk of being infected.
Until we get a perfect Vaccine/ Medicine that is 100% effective on all the evolving variants of Coronavirus, It’s strongly advised to follow few things. Yes! Just a few SIMPLE THINGS:
Wash hands frequently / Sanitize hands / Use gloves
Avoid public gatherings & traveling / frequent traveling
Eat food that boosts your immunity
Exercise to stay fit
Conclusion: Prevention is Better than Cure
The above review statements are those of the sponsor (Source of content) and do not necessarily reflect the official policy, position or views of the content publisher. The content distribution company is therefore not responsible for the content and its authenticity and legal standing of the above subject matter. Each individual is required to exercise its content when making a purchase from the above offer. The information does not constitute advice or an offer to buy. Any purchase made from the above press release is made at your own risk. Editorial merit of this content is subject to news publisher and its downstream partners. Consult an expert advisor/health and professional advisor before any such purchase. Any purchase made from this link is subject to the final terms and conditions of the website's selling as mentioned in the above as source. The content publisher and its downstream distribution partners do not take any responsibility directly or indirectly. If you have any complaints or copyright issues related to this article, kindly contact the company this news is about.
DISCLAIMER of Liability. IN NO EVENT SHALL OUR PR COMPANY BE LIABLE OR RESPONSIBLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING WITHOUT LIMITATION, LOST PROFITS OR LOST OPPORTUNITIES, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE AND REGARDLESS OF THE CAUSE OF ACTION UPON WHICH ANY SUCH CLAIM IS BASED, INCLUDING, WITHOUT LIMITATION, ANY CLAIM ARISING OUT OF OR IN CONNECTION WITH ANY OF THE CONTENT, INCLUDING, WITHOUT LIMITATION, AUDIO, PHOTOGRAPHS, AND VIDEOS, OR OF THE ACCURACY, RELIABILITY, OR LEGALITY OF ANY STATEMENT MADE IN OR OMITTED FROM ANY advertisement, sponsorship, endorsement, testimonial, opinion, or other product-related or service-related statement or review appearing in the Websites or in ANY post or article distributed via the Websites.
Published by: Book Club
Release ID: 17879